Savitz Ryan bought DNTH
July 9, 2026 · Form 4 insider transaction
Savitz Ryan bought 31,249 shares of Dianthus Therapeutics, Inc. at $21.77 per share, a transaction worth $680.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,249
Price
$21.77
Total value
$680.3K
InsiderSavitz Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after31,249
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.